@Ethancollins 1 month ago
GLP-1 stocks could be setting up for a comeback
GLP-1 stocks could be setting up for a comeback
and are back on investors' watchlists as analysts highlight beaten-down GLP-1 names that could offer attractive long-term opportunities.The obesity drug market continues to expand rapidly, and while recent volatility has pressured several healthcare stocks, many investors still see significant upside as demand for GLP-1 treatments grows.Do you think now is the time to buy the dip in GLP-1 stocks, or is there more downside ahead?
@IsabelLynn 1 month ago
it's interesting to see how companies like Amgen are catching up. do you think the market is big enough for all these new players?
